These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37357269)

  • 1. Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?
    Doody RS; Skerjanec S
    J Prev Alzheimers Dis; 2023; 10(3):344-345. PubMed ID: 37357269
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA approves 100th monoclonal antibody product.
    Mullard A
    Nat Rev Drug Discov; 2021 Jul; 20(7):491-495. PubMed ID: 33953368
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves first complement factor D inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 May; 23(5):329. PubMed ID: 38605116
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA center issues new guidelines, approves drugs.
    Printz C
    Cancer; 2021 Mar; 127(6):826. PubMed ID: 33689177
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves fifth RNAi drug - Alnylam's next-gen hATTR treatment.
    Mullard A
    Nat Rev Drug Discov; 2022 Aug; 21(8):548-549. PubMed ID: 35794463
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves first drug in new treatment category.
    AIDS Policy Law; 2003 Mar; 18(6):3. PubMed ID: 12712927
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approves levoleucovorin.
    Traynor K
    Am J Health Syst Pharm; 2008 Apr; 65(8):686. PubMed ID: 18387890
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approves first telomerase inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 Aug; 23(8):570. PubMed ID: 38877327
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves new antipsychotic.
    Traynor K
    Am J Health Syst Pharm; 2007 Feb; 64(3):222. PubMed ID: 17244863
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. FDA approves lipidatrophy drug.
    AIDS Alert; 2007 Mar; 22(3):31. PubMed ID: 17722336
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA tentatively approves generic efavirenz.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17577959
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves first drug for Parkinson disease psychosis.
    Mullard A
    Nat Rev Drug Discov; 2016 Jun; 15(6):375. PubMed ID: 27245388
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Nierengarten MB
    Cancer; 2024 Jun; 130(11):1903. PubMed ID: 38757625
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves third weight-loss drug.
    Harv Heart Lett; 2012 Jul; 22(11):8. PubMed ID: 27024442
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. FDA approves new Kaletra formulation.
    AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. FDA approves new dosing for Kaletra.
    AIDS Alert; 2010 Jun; 25(6):70-1. PubMed ID: 20623833
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves PI3K inhibitor for a rare immune disorder.
    Mullard A
    Nat Rev Drug Discov; 2023 May; 22(5):342. PubMed ID: 37041237
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approves new HIV drug after priority review.
    AIDS Patient Care STDS; 2008 Feb; 22(2):159. PubMed ID: 18260807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.